ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disability"

  • Abstract Number: 1478 • 2018 ACR/ARHP Annual Meeting

    Factors Associated with Disability and Health-Related Quality of Life in Biologic-Treated Patients with Rheumatoid Arthritis in Persistent Moderate Disease Activity

    Ian C. Scott1,2, Julie Mount3, Jane Barry3 and Bruce Kirkham4, 1Research Institute for Primary Care & Health Sciences, Primary Care Sciences, Keele University, Keele, United Kingdom, 2Department for Rheumatology, Haywood Hospital, Stoke on Trent, United Kingdom, 3Eli Lilly and Company, Basingstoke, United Kingdom, 4Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom

    Background/Purpose: A treat-to target (T2T) strategy is recommended for the management of rheumatoid arthritis (RA), with the target being remission or at least low disease…
  • Abstract Number: 2473 • 2018 ACR/ARHP Annual Meeting

    The Relation between Inflammatory Joint Activity and Disability Related to the Lower Extremities in Early Rheumatoid Arthritis

    Maria Mellblom Bengtsson1,2, Sofia Hagel3, Lennart Jacobsson4 and Carl Turesson1,2, 1Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, 2Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 3Rheumatology, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden, 4Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

     Background/Purpose: Arthritis in the lower extremities has a major impact in many patients in rheumatoid arthritis (RA), but has not been extensively studied. The objective…
  • Abstract Number: 229 • 2018 ACR/ARHP Annual Meeting

    Disability Status, Mortality, and Leading Causes of Death in Seropositive Rheumatoid Arthritis Patients: A Population-Based Study in Korea

    In Ah Choi1, Jeong Seok Lee2,3 and Eun Young Lee2, 1Division of Rheumatology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea, Republic of (South), 2Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South), 3Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea, Republic of (South)

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease that leads to functional disability and premature mortality. We aimed to identify the status of disability…
  • Abstract Number: 363 • 2017 ACR/ARHP Annual Meeting

    Work Productivity Benefit in Patients with Rheumatoid Arthritis Initiating Etanercept in the United States

    Mahdi Gharaibeh1, Bradley S. Stolshek2, Alex Mutebi3, Amy M. Sainski-Nguyen4, David Collier5 and Emily Durden4, 1Amgen Inc., Thousand Oaks, CA, 2Amgen, Inc., Thousand Oaks, CA, 3Amgen, Thousand Oaks, CA, 4Truven Health Analytics, Ann Arbor, MI, 5Amgen, Inc, Terni, Italy

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease that can progress to joint destruction, functional impairment and disability that can lead to work productivity…
  • Abstract Number: 936 • 2017 ACR/ARHP Annual Meeting

    Knee Confidence Trajectories over 8 Years and Factors Associated with Poor Trajectories: Data from the Osteoarthritis Initiative

    Alison H. Chang, Julia (Jungwha) Lee, Orit Almagor, Joan S. Chmiel, Kirsten C. Moisio, Karen W. Hayes, Julie Szymaszek and Leena Sharma, Northwestern University, Chicago, IL

    Background/Purpose: Lack of knee confidence, a frequent complaint, has been associated with function decline in knee OA. Given its key role in weight-bearing activities, a…
  • Abstract Number: 1370 • 2017 ACR/ARHP Annual Meeting

    Higher Disease Activity in Current Smokers with Established RA: Is It Disease, Damage or Disability?

    Emily Keeler1, Danielle Feger2, Nancy J. Olsen1 and Rayford R. June3, 1Medicine/Rheumatology, Penn State Hershey Medical Center, Hershey, PA, 2Medicine/Rheumatology, Penn State College of Medicine, Hershey, PA, 3Rheumatology, Penn State Hershey Medical Center, Hershey, PA

    Background/Purpose: Smoking is an important environmental risk factor for development of rheumatoid arthritis (RA). Smoking has been linked to lower rates of disease remission, incomplete…
  • Abstract Number: 1851 • 2017 ACR/ARHP Annual Meeting

    Improving Walking Ability in Degenerative Lumbar Spinal Stenosis: A Randomized Trial Comparing 2 Self-Management Training Programs

    Carlo Ammendolia1, Pierre Côté2, Danielle Southerst3, Michael Schneider4, Brian Budgell3, Claire Bombardier5, Gillian Hawker6 and Y. Raja Rampersaud7, 1Surgery, University of Toronto, Toronto, ON, Canada, 2University of Ontario Institute of Technology, Toronto, ON, Canada, 3Canadian Memorial Chiropractic College, Toronto, ON, Canada, 4University of Pittsburgh, Pittsburgh, PA, 5Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 6Professor, Full SGS Member Department of Medicine, University of Toronto Chief of Medicine, Women's College Hospital 76 Grenville Street 8th Floor East, Room 815, University of Toronto, Toronto, ON, Canada, 7University of Toronto, Toronto, ON, Canada

    Background/Purpose: Degenerative lumbar spinal stenosis (DLSS) is a leading cause of pain, disability and loss of independence in older adults. It is caused by age…
  • Abstract Number: 1867 • 2017 ACR/ARHP Annual Meeting

    Can Vs. Do: Using Walking Speed and Moderate-to-Vigorous Physical Activity to Predict Incident Low Health-Related Quality of Life and Disability

    Louise Thoma1, Hiral Master1, Meredith Christiansen1, Dana Mathews2 and Daniel White3, 1Physical Therapy and Biomechanics and Movement Science, University of Delaware, Newark, DE, 2Physical Therapy, Biomechanics and Movement Science, University of Delaware, Newark, DE, 3Department of Physical Therapy, University of Delaware, Newark, DE

    Background/Purpose: Walking speed is a measure of performance, i.e., what people “can” do, and is a known predictor of future health, disability, and mortality in…
  • Abstract Number: 2188 • 2017 ACR/ARHP Annual Meeting

    Risk of Disability in Underweight Persons with or at Increased Risk of Knee Osteoarthritis

    Nilasha Ghosh, Joan S. Chmiel, Orit Almagor, Karen W. Hayes, Kirsten C. Moisio, Alison H. Chang, Julie Szymaszek and Leena Sharma, Northwestern University, Chicago, IL

    Background/Purpose: US studies have revealed a U-shaped relationship between BMI and poor outcomes (function, mortality); both underweight and overweight/obese persons have greater risk. In knee…
  • Abstract Number: 2234 • 2017 ACR/ARHP Annual Meeting

    Disability in Acute Low Back Pain: The Role of Pain Severity, Pain Catastrophizing, Depression, and Exercise

    Elizabeth Salt1, Leslie J. Crofford2, Mary Kay Rayens3 and Suzanne Segerstrom4, 1University of Kentucky, Lexington, KY, 2Medicine, Vanderbilt University Medical Center, Nasville, TN, 3College of Nursing, University of Kentucky, Lexington, KY, 4Psychology, University of Kentucky, Lexington, KY

    Disability in Acute Low Back Pain: The Role of Pain Severity, Pain Catastrophizing, Depression, and ExerciseBackground/Purpose: The effectiveness of cognitive treatments for low back pain,…
  • Abstract Number: 2258 • 2017 ACR/ARHP Annual Meeting

    Real-World Evidence Linking Health-Related Quality of Life to Work Outcomes in Patients with Rheumatoid Arthritis

    Vibeke Strand1, Mark Kosinski2, Regina Rendas-Baum2, David Brooks3 and Rita Ganguly4, 1Division of Immunology/Rheumatology, Stanford University, Stanford, CA, 2Optum, Inc, Eden Prairie, MN, 3GlaxoSmithKline, Philadelphia, PA, 4GlaxoSmithKline, Collegeville, PA

    Background/Purpose: Evaluating health-related quality of life (HRQoL) scores is a key component of the management of rheumatoid arthritis (RA) and evaluation of treatment efficacy.  There…
  • Abstract Number: 2293 • 2017 ACR/ARHP Annual Meeting

    Can We Predict Achievement of Clinically Inactive Disease and Sustained Remission in Children with Juvenile Idiopathic Arthritis?

    Stephanie Shoop-Worrall1, Suzanne M Verstappen2, Janet E. McDonagh3, Wendy Thomson4 and Kimme L. Hyrich1, 1The University of Manchester, Arthritis Research UK Centre for Epidemiology, Manchester, United Kingdom, 2Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Arthritis Research UK Centre for Epidemiology, Manchester, United Kingdom, 3Faculty of Medical and Human Sciences, Centre for MSK Research, Manchester, United Kingdom, 4Arthritis Research UK Centre for Genetics and Genomics,The University of Manchester, Manchester, United Kingdom

    Background/Purpose: Identifying predictors for clinically inactive disease (CID) and sustained remission would allow rapid escalation of therapies for children less likely to achieve these states.…
  • Abstract Number: 2302 • 2017 ACR/ARHP Annual Meeting

    The Impact of JIA on Physician and Patient-Reported Outcomes over the First Five Years Following Diagnosis

    Stephanie Shoop-Worrall1, Suzanne M Verstappen2, Janet E. McDonagh3, Wendy Thomson4 and Kimme L. Hyrich4, 1The University of Manchester, Arthritis Research UK Centre for Epidemiology, Manchester, United Kingdom, 2Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal and Dermatology Research, Faculty of Medicine, Biology and Health, United Kingdom, University of Manchester, Manchester, United Kingdom, 3Faculty of Medical and Human Sciences, Centre for MSK Research, Manchester, United Kingdom, 4National Institute of Health Research Manchester Musculoskeletal Biomedical Research Centre, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom

    Background/Purpose: Information regarding longer-term outcomes in JIA largely pre-date the introduction of biologic therapies and have been cross-sectional. The aim of this analysis was to…
  • Abstract Number: 2377 • 2017 ACR/ARHP Annual Meeting

    Impact of Body Mass Index and Weight Loss on Incident Disability in Patients with Rheumatoid Arthritis

    Joshua Baker1, Ted R. Mikuls2, Bryant R. England3, Michael D. George4, Grant Cannon5, Harlan Sayles6, Brian Sauer5, Liron Caplan7 and Kaleb Michaud6, 1Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 3Division of Rheumatology & Immunology, Department of Internal Medicine, Nebraska-Western IA VA Health Care System & University of Nebraska Medical Center, Omaha, NE, 4Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 5Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 6University of Nebraska Medical Center, Omaha, NE, 7Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Obese patients with rheumatoid arthritis (RA) have greater disability in cross-sectional studies. There are no long-term studies that assess trajectories of disability among individuals…
  • Abstract Number: 2504 • 2017 ACR/ARHP Annual Meeting

    The Validation of Istanbul  Back Disability Index (IBDI) in Axial Spondyloarthritis Patients

    Tuncay Duruoz, Hatice Sule Baklacioglu, Sevtap Acer Kasman and Didem Erdem, PMR Department, Rheumatology Division, Marmara University School of Medicine, Istanbul, Turkey

    Background/Purpose: The IBDI was developed to assess the disability in patients with mechanical low back pain (1) which contains the 18 daily activities questions. The…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology